<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 12">
<meta name=Originator content="Microsoft Word 12">
<link rel=File-List href="cheminformatics_files/filelist.xml">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>every1</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Dan Fara</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>39</o:TotalTime>
  <o:LastPrinted>2008-01-16T22:35:00Z</o:LastPrinted>
  <o:Created>2008-01-16T22:37:00Z</o:Created>
  <o:LastSaved>2008-01-16T22:37:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>903</o:Words>
  <o:Characters>5152</o:Characters>
  <o:Lines>42</o:Lines>
  <o:Paragraphs>12</o:Paragraphs>
  <o:CharactersWithSpaces>6043</o:CharactersWithSpaces>
  <o:Version>12.00</o:Version>
 </o:DocumentProperties>
</xml><![endif]-->
<link rel=dataStoreItem href="cheminformatics_files/item0001.xml"
target="cheminformatics_files/props0002.xml">
<link rel=themeData href="cheminformatics_files/themedata.thmx">
<link rel=colorSchemeMapping href="cheminformatics_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:DrawingGridHorizontalSpacing>5.5 pt</w:DrawingGridHorizontalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>2</w:DisplayHorizontalDrawingGridEvery>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="--"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1107304683 0 0 159 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750139 0 0 159 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Footnote Text Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	vertical-align:super;}
span.MsoEndnoteReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Endnote Text Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:purple;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Endnote Text";}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Footnote Text";}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	mso-fareast-font-family:Calibri;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("cheminformatics_files/header.htm") fs;
	mso-footnote-continuation-separator:url("cheminformatics_files/header.htm") fcs;
	mso-endnote-separator:url("cheminformatics_files/header.htm") es;
	mso-endnote-continuation-separator:url("cheminformatics_files/header.htm") ecs;
	mso-endnote-numbering-style:arabic;}
@page Section1
	{size:8.5in 11.0in;
	margin:.5in .5in .5in .5in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;
	mso-endnote-numbering-style:arabic;}
 /* List Definitions */
 @list l0
	{mso-list-id:829104617;
	mso-list-type:hybrid;
	mso-list-template-ids:2028036 67698699 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0D8;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1
	{mso-list-id:1607881650;
	mso-list-template-ids:-2014121618;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2
	{mso-list-id:1710178801;
	mso-list-type:hybrid;
	mso-list-template-ids:1679559714 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l2:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l3
	{mso-list-id:2004970411;
	mso-list-type:hybrid;
	mso-list-template-ids:-941201304 -1155752650 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
table.MsoTableGrid
	{mso-style-name:"Table Grid";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:59;
	mso-style-unhide:no;
	border:solid black 1.0pt;
	mso-border-alt:solid black .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.5pt solid black;
	mso-border-insidev:.5pt solid black;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="2050"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US link=blue vlink=purple style='tab-interval:.5in'>

<div class=Section1>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><i style='mso-bidi-font-style:normal'><span style='font-size:16.0pt;
line-height:115%'>Section III</span></i></b><b style='mso-bidi-font-weight:
normal'><span style='font-size:16.0pt;line-height:115%'><span style='mso-tab-count:
1'> </span><o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;
line-height:115%'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><b style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;
line-height:115%'>Cheminformatics (in Drug Discovery)</span></b><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;line-height:
115%;mso-fareast-font-family:"Times New Roman";mso-bidi-font-style:italic'><o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><i style='mso-bidi-font-style:
normal'><span style='font-size:12.0pt;line-height:115%'><o:p>&nbsp;</o:p></span></i></p>

<p class=MsoNormal style='text-align:justify'><i style='mso-bidi-font-style:
normal'><span style='font-size:12.0pt;line-height:115%'>Tudor I. Oprea<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-style:italic'>There has been a strong impetus
to minimize research and development (R&amp;D) costs and the time lapse between
idea (e.g., target or lead identification) and drug, and to maximize the rate
of success of preclinical R&amp;D projects. Hence, there is a constant drive to
re-evaluate the preclinical research process, and to place a stronger emphasis
on science, rather than serendipity. This led to a plethora of “revolutionary”
methods, each promising to reduce significantly the time from idea to marketed
drug, in spite of the increased burden imposed by regulatory agencies and by
competition. Methods such as computer-aided drug design, combinatorial
chemistry, anti-sense technology and high-throughput screening (HTS) had their
share of enthusiasts; while useful in some cases, most of the new techniques
did not prove to be more than enabling technologies – useful, but short of
miraculous<a style='mso-endnote-id:edn1' href="#_edn1" name="_ednref1" title=""><span
class=MsoEndnoteReference><span style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;line-height:115%;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-bidi-font-style:italic'>[1]</span></span><![endif]></span></span></a>.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-style:italic'>One of the paramount efforts to
revise the input/output (or the signal noise) ratio with regards to chemical
aspects of drug discovery has been in the area of cheminformatics. In the
strictest sense, chemical informatics integrates data via computer-assisted
manipulation of chemical structures<a style='mso-endnote-id:edn2' href="#_edn2"
name="_ednref2" title=""><span class=MsoEndnoteReference><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;line-height:115%;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-bidi-font-style:italic'>[2]</span></span><![endif]></span></span></a>.
Chemical inventory and compound registration are vital to cheminformatics, but
it is their combination with other theoretical tools, linked to physical
(organic) chemistry, pharmacodynamics, and pharmacokinetics that bring unique
capabilities in the area of lead and drug discovery. In recent years,
cheminformatics has emerged as the informatics-driven technological push in
preclinical research, since it successfully link all the involved scientific
partners, from virtual screening to animal toxicology via one central element: <i>chemical
structure</i>. The following computational chemistry protocols are
cheminformatics activities associated to the drug discovery process:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.25in;
mso-list:l0 level1 lfo4'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings;mso-bidi-font-style:italic'><span
style='mso-list:Ignore'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-style:italic'>Chemical library (virtual or physical) analysis
(reagent- and product-based); this includes tools for molecular similarity and
diversity;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.25in;
mso-list:l0 level1 lfo4'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings;mso-bidi-font-style:italic'><span
style='mso-list:Ignore'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-style:italic'>Virtual screening (including docking and scoring);
this requires 3D structures of the receptor, as well as a model of the binding
site;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.25in;
mso-list:l0 level1 lfo4'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings;mso-bidi-font-style:italic'><span
style='mso-list:Ignore'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-style:italic'>Structure-activity relationships (SAR) for lead
series identification; if pharmacophore models are available, they can also be
used in virtual screening;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.25in;
mso-list:l0 level1 lfo4'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings;mso-bidi-font-style:italic'><span
style='mso-list:Ignore'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-style:italic'>Virtual or high-throughput screening
post-processing and analysis; this includes SAR for primary HTS data;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.25in;
mso-list:l0 level1 lfo4'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings;mso-bidi-font-style:italic'><span
style='mso-list:Ignore'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><i><span
style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:"Times New Roman"'>De-novo</span></i><span
style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-style:italic'> ligand design for lead generation and lead
optimization, when 3D structures of the ligand-receptor complex(es) are
available; if the receptor-bound conformation for high-affinity ligands is
determined experimentally, the chance for successful lead optimization is
increased;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.25in;
mso-list:l0 level1 lfo4'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings;mso-bidi-font-style:italic'><span
style='mso-list:Ignore'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-style:italic'>Quantitative structure-activity relationships
(QSAR) for lead hopping and lead optimization, in the absence of 3D structures
for the ligand-receptor complex; pharmacophoric patterns can be combined with
QSAR or 3D-QSAR techniques in order to increase model quality;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.25in;
mso-list:l0 level1 lfo4'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings;mso-bidi-font-style:italic'><span
style='mso-list:Ignore'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><i><span
style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:"Times New Roman"'>In-silico</span></i><span
style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-style:italic'> screening for ADME (Absorption, Distribution, Metabolism,
and Excretion), plasma protein binding, metabolism prediction, and toxicology,
in order to increase the quality of the compounds that reach late-phase
preclinical development;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;text-align:justify;text-indent:-.25in;
mso-list:l0 level1 lfo4'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;font-family:Wingdings;mso-fareast-font-family:Wingdings;
mso-bidi-font-family:Wingdings;mso-bidi-font-style:italic'><span
style='mso-list:Ignore'>Ø<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-style:italic'>Data mining and visualization tools with chemistry
awareness: Spotfire<sup>TM</sup> with the ISIS plug-in<a style='mso-endnote-id:
edn3' href="#_edn3" name="_ednref3" title=""><span class=MsoEndnoteReference><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;line-height:115%;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-bidi-font-style:italic'>[3]</span></span><![endif]></span></span></a>,
Leadscope<a style='mso-endnote-id:edn4' href="#_edn4" name="_ednref4" title=""><span
class=MsoEndnoteReference><span style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;line-height:115%;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-bidi-font-style:italic'>[4]</span></span><![endif]></span></span></a>, and
VIDA<a style='mso-endnote-id:edn5' href="#_edn5" name="_ednref5" title=""><span
class=MsoEndnoteReference><span style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;line-height:115%;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-bidi-font-style:italic'>[5]</span></span><![endif]></span></span></a> are
examples of tools that enhance the information available in the decision making
process by providing multiple visualizations, data-dependent filters,
substructure searching, and 2D and 3D molecular structures, in order to
facilitate understanding of the molecules of interest, and their neighbors, in
multi-dimensional spaces, often in a receptor-relevant context.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-style:italic'>While the goal of transforming
data into information, and information into knowledge<a style='mso-endnote-id:
edn6' href="#_edn6" name="_ednref6" title=""><span class=MsoEndnoteReference><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;line-height:115%;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-bidi-font-style:italic'>[6]</span></span><![endif]></span></span></a>, is
cheminformatics, we consider access to biological (and indeed chemical) data,
but <i>not</i> the data themselves, as part of cheminformatics<a
name="_Ref188260766"></a><a style='mso-endnote-id:edn7' href="#_edn7"
name="_ednref7" title=""><span style='mso-bookmark:_Ref188260766'><span
class=MsoEndnoteReference><span style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;line-height:115%;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-bidi-font-style:italic'>[7]</span></span><![endif]></span></span></span></a><span
style='mso-bookmark:_Ref188260766'></span>. By the same token, several
number-crunching activities traditionally associated with computational
chemistry, e.g., physical and chemical property calculations, generate more
numbers, rather than information. In other words, traditional computational
chemistry may not necessarily be part of cheminformatics unless it assists
decision-makers to interpret or to clarify the initial physicochemical,
structural, and biological data. For example, virtual screening and QSARs
transform numbers (data) into models (information, even knowledge), and should
therefore be considered an integral part of cheminformatics.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify'><span style='font-size:12.0pt;line-height:115%;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-style:italic'>Similar to the role envisioned
for medicinal chemistry in the new millennium by Erhardt<a name="_Ref188260384"></a><a
style='mso-endnote-id:edn8' href="#_edn8" name="_ednref8" title=""><span
style='mso-bookmark:_Ref188260384'><span class=MsoEndnoteReference><span
style='mso-special-character:footnote'><![if !supportFootnotes]><span
class=MsoEndnoteReference><span style='font-size:12.0pt;line-height:115%;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-bidi-font-style:italic'>[8]</span></span><![endif]></span></span></span></a><span
style='mso-bookmark:_Ref188260384'></span>, a major role will be played by
cheminformatics in drug discovery in the first decades of the 21<sup>st</sup>
century, as the central instrument for chemistry-related information. This
information, however, is unlikely to be transformed into knowledge by medicinal
chemists alone<sup><span style='mso-field-code:" NOTEREF _Ref188260384 \\h &#1; \\* MERGEFORMAT "'>8<!--[if gte mso 9]><xml>
 <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F005200650066003100380038003200360030003300380034000000</w:data>
</xml><![endif]--></span></sup>, as the interpretation basis for such decisions
requires in-depth knowledge in several, unrelated, fields: physical organic
chemistry (for solubility and passive transcellular permeability), medicinal
and combinatorial chemistry (for synthetic prioritization and retrosynthetic
analyses), process chemistry (reducing the number of synthetic steps),
pharmacology and physiology (for pharmacodynamics and efficacy), and
pharmacokinetics and toxicology (for ADME, metabolic stability, acute and
chronic toxicity), to name but a few. Although not enabling such competence <i>per
se</i>, cheminformatics is a computer-based tool primed to assist decision-makers
in the drug discovery processes<sup><span style='mso-field-code:" NOTEREF _Ref188260766 \\h &#1; \\* MERGEFORMAT "'>7<!--[if gte mso 9]><xml>
 <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F005200650066003100380038003200360030003700360036000000</w:data>
</xml><![endif]--></span></sup>. While it is apparently objective, its
computational techniques are ultimately dependent on the (subjective) concepts
and thinking that go into the models and assumptions onto which they were
built. Thus, cheminformatics provides a forum for the necessary dialogue
between theoretical sciences, and experimental chemistry and biology.<o:p></o:p></span></p>

</div>

<div style='mso-element:endnote-list'><![if !supportEndnotes]><br clear=all>

<hr align=left size=1 width="33%">

<![endif]>

<div style='mso-element:endnote' id=edn1>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn1' href="#_ednref1"
name="_edn1" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[1]</span></span><![endif]></span></span></a>
Horrobin, D.F. <i style='mso-bidi-font-style:normal'>J. Royal Soc. Med.</i> <b
style='mso-bidi-font-weight:normal'>2000</b>, <i style='mso-bidi-font-style:
normal'>93</i>, 341-345.</p>

</div>

<div style='mso-element:endnote' id=edn2>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn2' href="#_ednref2"
name="_edn2" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[2]</span></span><![endif]></span></span></a>
Brown, F. <i style='mso-bidi-font-style:normal'>Annu. Rep. Med. Chem.</i>, <b
style='mso-bidi-font-weight:normal'>1998</b>, <i style='mso-bidi-font-style:
normal'>33</i>, 375-384.</p>

</div>

<div style='mso-element:endnote' id=edn3>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn3' href="#_ednref3"
name="_edn3" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[3]</span></span><![endif]></span></span></a>
Potfire and the ISIS Substructure Visualizer (SSV) are available from Spotfire
Inc., Göteborg, Sweden; <a href="http://spotfire.tibco.com/">http://spotfire.tibco.com/</a>
</p>

</div>

<div style='mso-element:endnote' id=edn4>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn4' href="#_ednref4"
name="_edn4" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[4]</span></span><![endif]></span></span></a>
Roberts, G.; Myatt, G.J.; Johnson, K.P.; Cross, K.P.; Blower, P.E., Jr. <i
style='mso-bidi-font-style:normal'>J. Chem. Inf. Comput. Sci.</i> <b
style='mso-bidi-font-weight:normal'>2000</b>, <i style='mso-bidi-font-style:
normal'>40</i>, 1302-1314; Leadscope is available from Leadscope Inc., <a
href="http://www.leadscope.com/">http://www.leadscope.com/</a> </p>

</div>

<div style='mso-element:endnote' id=edn5>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn5' href="#_ednref5"
name="_edn5" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[5]</span></span><![endif]></span></span></a>
VIDA is available from OpenEye Scientific Software, Santa Fe, New Mexico; <a
href="http://www.eyesopen.com">http://www.eyesopen.com</a> </p>

</div>

<div style='mso-element:endnote' id=edn6>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn6' href="#_ednref6"
name="_edn6" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[6]</span></span><![endif]></span></span></a>
Hahn, M.M.; Green, R. <i style='mso-bidi-font-style:normal'>Curr. Opin. Drug.
Discov. Dev.</i> <b style='mso-bidi-font-weight:normal'>1999</b>, <i
style='mso-bidi-font-style:normal'>3</i>, 379-383.</p>

</div>

<div style='mso-element:endnote' id=edn7>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn7' href="#_ednref7"
name="_edn7" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[7]</span></span><![endif]></span></span></a>
Olsson, T.; Oprea, T.I. <i style='mso-bidi-font-style:normal'>Curr. Opin. Drug.
Discov. Dev.</i> <b style='mso-bidi-font-weight:normal'>2001</b>, <i
style='mso-bidi-font-style:normal'>4</i>, 308-313.</p>

</div>

<div style='mso-element:endnote' id=edn8>

<p class=MsoEndnoteText><a style='mso-endnote-id:edn8' href="#_ednref8"
name="_edn8" title=""><span class=MsoEndnoteReference><span style='mso-special-character:
footnote'><![if !supportFootnotes]><span class=MsoEndnoteReference><span
style='font-size:10.0pt;line-height:115%;font-family:"Times New Roman","serif";
mso-fareast-font-family:Calibri;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'>[8]</span></span><![endif]></span></span></a>
Erhardt, W.P. <i style='mso-bidi-font-style:normal'>Pure Appl. Chem.</i> <b
style='mso-bidi-font-weight:normal'>2002</b>, <i style='mso-bidi-font-style:
normal'>74</i>, 703-785.</p>

</div>

</div>

</body>

</html>
